摘要
目的:探讨新生儿肺炎患者采用阿莫西林克拉维酸钾治疗的临床疗效。方法:收治新生儿肺炎患者100例,随机分为两组。对照组给予氨苄西林治疗,观察组给予阿莫西林克拉维酸钾治疗,对比两组患儿的疗效。结果:治疗组中患儿总有效率92%,显著高于对照组的56%,两组差异具有统计学意义(P<0.05)。相较于对照组患儿,观察组患者的疗程、临床症状和体征消失时间均相对较短,两组差异具有统计学意义(P<0.05)。结论:通过对新生儿肺炎患者行阿莫西林克拉维酸钾治疗,有助于提高疾病治疗有效率,缩短治疗时间,降低不良反应发生率。
Objective:To investigate the clinical efficacy of amoxicillin and clavulanate potassium in the treatment of neonatal pneumonia.Methods:100 cases with neonatal pneumonia were selected.They were randomly divided into the two groups.The control group was treated with ampicillin.The observation group was treated with amoxicillin and potassium clavulanate.The curative effect of the two groups were compared.Results:The total effective rate of treatment group was 92% ,which was significantly higher than 56% of the control group,and the difference between groups was statistically significant(P<0.05).Compared with the control group,the observation group of patients with treatment time and other adverse reaction time were relatively short,and the difference between groups was statistically significant(P<0.05).Conclusion:The treatment of neonatal pneumonia patients with amoxicillin and clavulanate can help to improve the efficiency of disease treatment,shorten the treatment time,reduce the incidence of adverse reactions.
作者
毛丽莉
Mao Lili(Department of Paediatrics,the People's Hospital of Renhuai City,Guizhou Province 564500)
出处
《中国社区医师》
2017年第7期66-66,68,共2页
Chinese Community Doctors
关键词
阿莫西林克拉维酸钾
新生儿
肺炎
Amoxicillin potassium clavulanate
Newborn
Pneumonia